Literature DB >> 11337096

Cardiovascular actions of CRH and urocortin: an update.

D G Parkes1, R S Weisinger, C N May.   

Abstract

Urocortin is a potent regulator of cardiac function, with actions that are prolonged in experimental animals. These changes are mediated via binding to CRH receptors found in peripheral tissues. The diversity of actions of urocortin on behaviour, appetite, inflammation and the cardiovascular system suggest that this peptide may be an endogenous factor mediating actions previously attributed to CRH. The present review will focus on the recent understanding of mechanisms mediating the cardiovascular actions of urocortin and CRH reported to date.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11337096     DOI: 10.1016/s0196-9781(01)00396-5

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  16 in total

1.  NFAT transcription factor regulation by urocortin II in cardiac myocytes and heart failure.

Authors:  Stefanie Walther; Sawsan Awad; Vassyl A Lonchyna; Lothar A Blatter
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-01-17       Impact factor: 4.733

Review 2.  Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs.

Authors:  Eva M Fekete; Eric P Zorrilla
Journal:  Front Neuroendocrinol       Date:  2006-11-02       Impact factor: 8.606

3.  cAMP- and Ca²(+) /calmodulin-dependent protein kinases mediate inotropic, lusitropic and arrhythmogenic effects of urocortin 2 in mouse ventricular myocytes.

Authors:  Li-Zhen Yang; Jens Kockskämper; Shelina Khan; Jorge Suarez; Stefanie Walther; Bernhard Doleschal; Gregor Unterer; Mounir Khafaga; Heinrich Mächler; Frank R Heinzel; Wolfgang H Dillmann; Burkert Pieske; Joachim Spiess
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

4.  Fractal dynamics of heart beat interval fluctuations in corticotropin-releasing factor receptor subtype 2 deficient mice.

Authors:  Oliver Stiedl; Michael Meyer
Journal:  Integr Physiol Behav Sci       Date:  2002 Oct-Dec

5.  Mechanisms of relaxation by urocortin in renal arteries from male and female rats.

Authors:  Elena Sanz; Luis Monge; Nuria Fernández; Belén Climent; Godofredo Diéguez; Angel Luis Garcia-Villalón
Journal:  Br J Pharmacol       Date:  2003-09-29       Impact factor: 8.739

6.  Urocortin 2 autocrine/paracrine and pharmacologic effects to activate AMP-activated protein kinase in the heart.

Authors:  Ji Li; Dake Qi; Haiying Cheng; Xiaoyue Hu; Edward J Miller; Xiaohong Wu; Kerry S Russell; Nicole Mikush; Jiasheng Zhang; Lei Xiao; Robert S Sherwin; Lawrence H Young
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

7.  Fractal dynamics in circadian cardiac time series of corticotropin-releasing factor receptor subtype-2 deficient mice.

Authors:  O Stiedl; M Meyer
Journal:  J Math Biol       Date:  2003-03-19       Impact factor: 2.259

8.  Fractal rigidity by enhanced sympatho-vagal antagonism in heartbeat interval dynamics elicited by central application of corticotropin-releasing factor in mice.

Authors:  M Meyer; O Stiedl
Journal:  J Math Biol       Date:  2006-03-06       Impact factor: 2.259

9.  The Modulation of Cardiac Contractile Function by the Pharmacological and Toxicological Effects of Urocortin2.

Authors:  Si Chen; Zhenhua Wang; Bo Xu; Xiangquan Mi; Wanqing Sun; Nanhu Quan; Lin Wang; Xingchi Chen; Quan Liu; Yang Zheng; Jiyan Leng; Ji Li
Journal:  Toxicol Sci       Date:  2015-09-04       Impact factor: 4.849

10.  The impact of stress on tumor growth: peripheral CRF mediates tumor-promoting effects of stress.

Authors:  Alicia Arranz; Maria Venihaki; Berber Mol; Ariadne Androulidaki; Erini Dermitzaki; Olga Rassouli; Jorge Ripoll; Efstathios N Stathopoulos; Rosa P Gomariz; Andrew N Margioris; Christos Tsatsanis
Journal:  Mol Cancer       Date:  2010-09-27       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.